GuidelineAnnals of the rheumatic diseases2006
ASAS/EULAR recommendations for the management of ankylosing spondylitis.
Guideline in Annals of the rheumatic diseases, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 199 papers, 10 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
Examining the Effect of Home-Based Exercise on Disease Activity in Patients With Ankylosing Spondylitis Using SIRI (Systemic Inflammatory Response Index) and SII (Systemic Inflammation Index): A Randomized Controlled Trial
Who cites it
199 citing papers in PubMed, 10 syntheses or guidelines pooled it.
- Neuropathic pain in ankylosing spondylitis: a meta-analysis.Zeitschrift fur Rheumatologie · 2020Pooled it
- Pooled it
- Etanercept in the treatment of ankylosing spondylitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials, and the comparison of the Caucasian and Chinese population.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2013Pooled it
- Cost effectiveness of therapeutic interventions in ankylosing spondylitis: a critical and systematic review.PharmacoEconomics · 2012Pooled it
- 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.Annals of the rheumatic diseases · 2011Pooled it
- Treatment recommendations for psoriatic arthritis.Annals of the rheumatic diseases · 2009Guideline
- Physiotherapy interventions for ankylosing spondylitis.The Cochrane database of systematic reviews · 2008Pooled it
- EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).Annals of the rheumatic diseases · 2006Guideline
- EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology.British journal of sports medicine · 2006Pooled it
- Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.Annals of the rheumatic diseases · 2006Pooled it
- Effects of telerehabilitation and YouTube platform-based exercise videos in patients with axial spondyloarthritis: a randomized controlled study.Clinical rheumatology · 2025Trial
- Comparison of Yoga with exercise in ankylosing spondylitis on mobility and functional capacity.International journal of rheumatic diseases · 2024Trial
- The effectiveness of hippotherapy simulation exercises for muscle strength, disease activity and quality of life in sedentary adults with ankylosing spondylitis.Annals of medicine · 2023Trial
- Clinical Efficacy of Modified Yanghe Decoction in Ankylosing Spondylitis: A Randomized Controlled Trial.Medical science monitor : international medical journal of experimental and clinical research · 2018Trial
- Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1).Arthritis & rheumatology (Hoboken, N.J.) · 2016Trial
- A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.BMC musculoskeletal disorders · 2016Trial
- Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial.European radiology · 2016Trial
- Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients.The Journal of international medical research · 2016Trial
- Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial.Rheumatology international · 2016Trial
- Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern/Central Europe, Latin America, and Asia.Rheumatology international · 2016Trial
139 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop evidence based recommendations for the management of ankylosing spondylitis (AS) as a combined effort of the 'ASsessment in AS' international working group and the European League Against Rheumatism.
methodsEach of the 22 participants was asked to contribute up to 15 propositions describing key clinical aspects of AS management. A Delphi process was used to select 10 final propositions. A systematic literature search was then performed to obtain scientific evidence for each proposition. Outcome data for efficacy, adverse effects, and cost effectiveness were abstracted. The effect size, relative risk, number needed to treat, and incremental cost effectiveness ratio were calculated. On the basis of the search results, 10 major recommendations for the management of AS were constructed. The strength of recommendation was assessed based on the strength of the literature evidence, risk-benefit trade-off, and clinical expertise.
resultsThe final recommendations considered the use of non-steroidal anti-inflammatory drugs (NSAIDs) (conventional NSAIDs, coxibs, and co-prescription of gastroprotective agents), disease modifying antirheumatic drugs, treatments with biological agents, simple analgesics, local and systemic steroids, non-pharmacological treatment (including education, exercise, and physiotherapy), and surgical interventions. Three general recommendations were also included. Research evidence (categories I-IV) supported 11 interventions in the treatment of AS. Strength of recommendation varied, depending on the category of evidence and expert opinion.
conclusionTen key recommendations for the treatment of AS were developed and assessed using a combination of research based evidence and expert consensus. Regular updating will be carried out to keep abreast of new developments in the management of AS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.